Jian Dai

Title: The Innovative Contributions of Jian Dai

Introduction

Jian Dai is a notable inventor based in South San Francisco, CA, who has made significant contributions to the field of medical technology. His work primarily focuses on developing advanced systems for predicting treatment intensity for age-related macular degeneration. With a keen interest in neural networks, Dai has successfully integrated artificial intelligence into medical imaging.

Latest Patents

Dai holds a patent for a "Deep neural network framework for processing OCT images to predict treatment intensity." This innovative patent relates to systems and methods for processing optical coherence tomography (OCT) images. The technology aims to predict the characteristics of treatments that can effectively address age-related macular degeneration. The process involves pre-processing the images by flattening and cropping them, followed by analysis using a deep convolutional neural network. The output from this neural network can indicate the predicted frequency and interval for administering treatments, such as anti-vascular endothelial growth factor therapy, to prevent vascular leakage in the eye.

Career Highlights

Jian Dai is currently employed at Genentech, Inc., a leading biotechnology company known for its focus on innovative medicines. His role at Genentech allows him to work at the forefront of medical technology, contributing to advancements that can significantly improve patient outcomes.

Collaborations

Dai collaborates with talented professionals in his field, including Michael Gregg Kawczynski and Jeffrey R. Willis. These collaborations enhance the development of innovative solutions in medical imaging and treatment prediction.

Conclusion

Jian Dai's contributions to the field of medical technology through his patent and work at Genentech highlight the importance of innovation in healthcare. His efforts in utilizing deep neural networks for processing OCT images represent a significant advancement in predicting treatment intensity for age-related macular degeneration.